image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9415929_medicina-58-01077-f002_386495.jpg | What is the dominant medical problem in this image? | Representative endoscopic images of gastroesophageal varices. (A): Normal; (B): Normal, (C): F1RC0, (D): F1RC0, (E): F2RC0, (F): F2RC1. |
PMC9415929_medicina-58-01077-f002_386494.jpg | What is being portrayed in this visual content? | Representative endoscopic images of gastroesophageal varices. (A): Normal; (B): Normal, (C): F1RC0, (D): F1RC0, (E): F2RC0, (F): F2RC1. |
PMC9415932_membranes-12-00760-f002_386504.jpg | What is shown in this image? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386513.jpg | What key item or scene is captured in this photo? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386506.jpg | What is the dominant medical problem in this image? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386517.jpg | What is the principal component of this image? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386515.jpg | What is being portrayed in this visual content? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386505.jpg | What is the dominant medical problem in this image? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386507.jpg | What can you see in this picture? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415932_membranes-12-00760-f002_386514.jpg | What key item or scene is captured in this photo? | SlDRP1B localizes to a subset of MVB/LE/PVC compartments. Localization of SlDRP1B was analyzed by confocal microscopy of N. benthamiana epidermal cells transiently expressing SlDRP1B-GFP and different endomembrane compartment markers as indicated. Images were acquired using a Zeiss LSM 780 microscope. (A) Representativ... |
PMC9415974_vaccines-10-01276-f001_386525.jpg | What is the central feature of this picture? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386522.jpg | What is the main focus of this visual representation? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386524.jpg | What is being portrayed in this visual content? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386519.jpg | What's the most prominent thing you notice in this picture? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386521.jpg | What stands out most in this visual? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386520.jpg | What stands out most in this visual? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386526.jpg | What is the central feature of this picture? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415974_vaccines-10-01276-f001_386523.jpg | What can you see in this picture? | A 70-year-old male patient was admitted with neck and shoulder pain accompanied by numbness and fatigue for 12 days. (a) Cervical X-ray at 6 days after vaccination (D6) showed straightening of cervical curvature and hyperosteogeny. (b) On D6, plain CT scan of cervical spine showed hyperosteogeny of cervical spine and s... |
PMC9415977_medicina-58-01128-f001_386529.jpg | What is the dominant medical problem in this image? | Evaluation of pulmonary arterial stiffness (PAS) by echocardiography. PAS (kHz/ms) = maximum frequency shift (MFS)/pulmonary flow acceleration time (PAT). |
PMC9415977_medicina-58-01128-f001_386528.jpg | What is the principal component of this image? | Evaluation of pulmonary arterial stiffness (PAS) by echocardiography. PAS (kHz/ms) = maximum frequency shift (MFS)/pulmonary flow acceleration time (PAT). |
PMC9415977_medicina-58-01128-f001_386527.jpg | What stands out most in this visual? | Evaluation of pulmonary arterial stiffness (PAS) by echocardiography. PAS (kHz/ms) = maximum frequency shift (MFS)/pulmonary flow acceleration time (PAT). |
PMC9415991_nanomaterials-12-02873-f001_386534.jpg | What's the most prominent thing you notice in this picture? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415991_nanomaterials-12-02873-f001_386533.jpg | What is the focal point of this photograph? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415991_nanomaterials-12-02873-f001_386535.jpg | What key item or scene is captured in this photo? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415991_nanomaterials-12-02873-f001_386532.jpg | What key item or scene is captured in this photo? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415991_nanomaterials-12-02873-f001_386530.jpg | What is the central feature of this picture? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415991_nanomaterials-12-02873-f001_386538.jpg | What is being portrayed in this visual content? | TEM images of Beta-OTF products crystallized for (a) 1, (b–d) 4, (e–g) 8 and (h,i) 18.5 h; areas of α, β, γ and δ in the Figure (b,c,e,f) are enlarged as Figure (c,d,f,g). Reprinted with permission from ref. [37]. Copyright 2011, The Royal Society of Chemistry. |
PMC9415997_medicina-58-01098-f003_386539.jpg | What is the main focus of this visual representation? | Anteroposterior radiograph of a pelvic malunion with internal rotation deformity of the right hemipelvis demonstrating diagonal distance from the low border of the sacroiliac joint to the bottom of the radiographic tear drop in skeletally mature patients. |
PMC9416000_F1_386542.jpg | What key item or scene is captured in this photo? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386541.jpg | What is the main focus of this visual representation? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386545.jpg | What is the focal point of this photograph? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386547.jpg | What key item or scene is captured in this photo? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386543.jpg | What's the most prominent thing you notice in this picture? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386546.jpg | What is the focal point of this photograph? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386544.jpg | What is the central feature of this picture? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F1_386540.jpg | What does this image primarily show? | Diffusion kurtosis imaging (DKI) parameter image. (A) FA: fractional anisotropy; (B) MD: mean diffusion; (C) Da: axial diffusion; (D) Dr: radial diffusion; (E) FAK: fractional anisotropy of kurtosis; (F) MK: mean kurtosis; (G) Ka: axial kurtosis; (H) Kr: radial kurtosis. |
PMC9416000_F2_386548.jpg | What is the focal point of this photograph? | Region of interest (ROI) placement diagram. The selected ROIs are shown on the T1 maps. (A) temporal lobe and hippocampus; (B) frontal lobe; (C) parietal lobe; (D) occipital lobe; (E) precuneus; (F) splenium of the corpus callosum and genu of the corpus callosum; (G) posterior limb of the internal capsule and lenticula... |
PMC9416000_F2_386549.jpg | What stands out most in this visual? | Region of interest (ROI) placement diagram. The selected ROIs are shown on the T1 maps. (A) temporal lobe and hippocampus; (B) frontal lobe; (C) parietal lobe; (D) occipital lobe; (E) precuneus; (F) splenium of the corpus callosum and genu of the corpus callosum; (G) posterior limb of the internal capsule and lenticula... |
PMC9416000_F2_386551.jpg | What's the most prominent thing you notice in this picture? | Region of interest (ROI) placement diagram. The selected ROIs are shown on the T1 maps. (A) temporal lobe and hippocampus; (B) frontal lobe; (C) parietal lobe; (D) occipital lobe; (E) precuneus; (F) splenium of the corpus callosum and genu of the corpus callosum; (G) posterior limb of the internal capsule and lenticula... |
PMC9416005_micromachines-13-01247-f002_386554.jpg | What object or scene is depicted here? | (a) Pure PDMS; (b) SEM image of carbon black particles; (c) CB/PDMS composite; (d) mesh structure of 3D printed composite; (e) conductive path change of CB/PDMS composite during mechanical deformation. |
PMC9416005_micromachines-13-01247-f002_386555.jpg | Can you identify the primary element in this image? | (a) Pure PDMS; (b) SEM image of carbon black particles; (c) CB/PDMS composite; (d) mesh structure of 3D printed composite; (e) conductive path change of CB/PDMS composite during mechanical deformation. |
PMC9416005_micromachines-13-01247-f002_386552.jpg | Describe the main subject of this image. | (a) Pure PDMS; (b) SEM image of carbon black particles; (c) CB/PDMS composite; (d) mesh structure of 3D printed composite; (e) conductive path change of CB/PDMS composite during mechanical deformation. |
PMC9416005_micromachines-13-01247-f002_386553.jpg | What object or scene is depicted here? | (a) Pure PDMS; (b) SEM image of carbon black particles; (c) CB/PDMS composite; (d) mesh structure of 3D printed composite; (e) conductive path change of CB/PDMS composite during mechanical deformation. |
PMC9416006_sensors-22-06314-f002_386558.jpg | What's the most prominent thing you notice in this picture? | (a) In red, the surface of the buildings registered in the cadastre of the Città Metropolitana di Torino. In yellow, the centroids of the buildings that are covered by vegetation; (b) Tree cover density, dominant leaf type, and forest type products for reference year 2018 in 10 m resolution (High-Resolution Layers—Fore... |
PMC9416017_toxins-14-00555-f005_386569.jpg | What stands out most in this visual? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386571.jpg | Can you identify the primary element in this image? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386563.jpg | What is the core subject represented in this visual? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386570.jpg | What is the principal component of this image? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386562.jpg | What key item or scene is captured in this photo? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386565.jpg | What is the core subject represented in this visual? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386567.jpg | What can you see in this picture? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416017_toxins-14-00555-f005_386566.jpg | What's the most prominent thing you notice in this picture? | Transmission electron microscopic examination of M. usitatus following treatment with mycelial extracts from Beauveria bassiana wild isolate and space mutants. Arrow marks points with variations in M. usitatus midgut anatomy following different treatment. |
PMC9416018_polymers-14-03317-f003_386561.jpg | What is the core subject represented in this visual? | TEM images of CNF at two magnifications whose scale are: (a) 2 µm and (b) 200 nm. |
PMC9416038_pathogens-11-00909-f001_386573.jpg | What is the main focus of this visual representation? | Microscopic lesions in stranded cetaceans with Toxoplasma gondii infection. Hematoxylin and eosin (HE) staining. (a) Skeletal muscle (case #6). Toxoplasma-like tissue cyst. (b) Brain frontal cortex (case #7). Severe non-suppurative necrotizing encephalitis in the presence of several Toxoplasma-like tissue cysts (asteri... |
PMC9416038_pathogens-11-00909-f001_386572.jpg | What does this image primarily show? | Microscopic lesions in stranded cetaceans with Toxoplasma gondii infection. Hematoxylin and eosin (HE) staining. (a) Skeletal muscle (case #6). Toxoplasma-like tissue cyst. (b) Brain frontal cortex (case #7). Severe non-suppurative necrotizing encephalitis in the presence of several Toxoplasma-like tissue cysts (asteri... |
PMC9416044_sensors-22-06198-f011_386575.jpg | What is the dominant medical problem in this image? | Drawing effect of four matching algorithms. (a) ICP-mapping, (b) GICP-mapping, (c) NDT-mapping, (d) NDT_OMP-mapping. |
PMC9416044_sensors-22-06198-f011_386576.jpg | What is shown in this image? | Drawing effect of four matching algorithms. (a) ICP-mapping, (b) GICP-mapping, (c) NDT-mapping, (d) NDT_OMP-mapping. |
PMC9416044_sensors-22-06198-f011_386577.jpg | What object or scene is depicted here? | Drawing effect of four matching algorithms. (a) ICP-mapping, (b) GICP-mapping, (c) NDT-mapping, (d) NDT_OMP-mapping. |
PMC9416062_tomography-08-00176-f003_386579.jpg | What is the main focus of this visual representation? | Group differences for the Body Projection experiment. First row Males greater than Females for male bodies, second row Females greater than Males for female bodies, and third row Females greater than Males for asexual bodies. In red significant clusters (p corr < 0.05) on a gray matter ICBM brain template, neurological... |
PMC9416062_tomography-08-00176-f003_386578.jpg | What is the central feature of this picture? | Group differences for the Body Projection experiment. First row Males greater than Females for male bodies, second row Females greater than Males for female bodies, and third row Females greater than Males for asexual bodies. In red significant clusters (p corr < 0.05) on a gray matter ICBM brain template, neurological... |
PMC9416062_tomography-08-00176-f004_386580.jpg | What stands out most in this visual? | Group differences for the Static Morphing experiment. First row Males greater than Females for looking at own face, second row Females greater than Males for looking at feminized faces. In red significant clusters (p corr < 0.05) on a gray matter ICBM brain template, neurological convention, color scale in the bar maps... |
PMC9416062_tomography-08-00176-f005_386581.jpg | What does this image primarily show? | Group differences for the Dynamic Morphing experiment. All the rows Females greater than Males for masculinization (first row), defeminization (second row) and feminization (third row) morphings. In red significant clusters (p corr < 0.05) on a gray matter ICBM brain template, neurological convention, color scale in th... |
PMC9416078_pharmaceutics-14-01742-f003_386584.jpg | Can you identify the primary element in this image? | Films’ swelling after the addition of 100 μL of phosphate buffer solution with pH 5.6 at the time point of (A) t = 0 s and (B) t = 5 s, after the addition of the solution. |
PMC9416078_pharmaceutics-14-01742-f003_386583.jpg | What can you see in this picture? | Films’ swelling after the addition of 100 μL of phosphate buffer solution with pH 5.6 at the time point of (A) t = 0 s and (B) t = 5 s, after the addition of the solution. |
PMC9416085_tomography-08-00164-f001_386585.jpg | What key item or scene is captured in this photo? | Coronary angiography and cardiac MRI. (A) The right coronary artery only had a mild plaque (<30% luminal diameter) in the mid portion, whereas in (B) the left main stem, left anterior descending artery, and circumflex artery had no evidence of coronary plaques. (C) T2-weighted 3-chamber view on cardiac MRI, showing foc... |
PMC9416085_tomography-08-00164-f001_386587.jpg | What object or scene is depicted here? | Coronary angiography and cardiac MRI. (A) The right coronary artery only had a mild plaque (<30% luminal diameter) in the mid portion, whereas in (B) the left main stem, left anterior descending artery, and circumflex artery had no evidence of coronary plaques. (C) T2-weighted 3-chamber view on cardiac MRI, showing foc... |
PMC9416085_tomography-08-00164-f001_386586.jpg | What object or scene is depicted here? | Coronary angiography and cardiac MRI. (A) The right coronary artery only had a mild plaque (<30% luminal diameter) in the mid portion, whereas in (B) the left main stem, left anterior descending artery, and circumflex artery had no evidence of coronary plaques. (C) T2-weighted 3-chamber view on cardiac MRI, showing foc... |
PMC9416085_tomography-08-00164-f001_386588.jpg | What is the principal component of this image? | Coronary angiography and cardiac MRI. (A) The right coronary artery only had a mild plaque (<30% luminal diameter) in the mid portion, whereas in (B) the left main stem, left anterior descending artery, and circumflex artery had no evidence of coronary plaques. (C) T2-weighted 3-chamber view on cardiac MRI, showing foc... |
PMC9416085_tomography-08-00164-f004_386590.jpg | What can you see in this picture? | Magnetic Resonance Imaging of Case 2. Post-contrast magnitude inversion recovery (MAG-IR) (A) and phase-sensitive inversion recovery (PSIR) (B) images in short-axis views show subepicardial enhancement in the inferolateral wall at the base (arrowheads). Native T1 map shows corresponding abnormality (arrowheads in (C)) ... |
PMC9416085_tomography-08-00164-f004_386591.jpg | What can you see in this picture? | Magnetic Resonance Imaging of Case 2. Post-contrast magnitude inversion recovery (MAG-IR) (A) and phase-sensitive inversion recovery (PSIR) (B) images in short-axis views show subepicardial enhancement in the inferolateral wall at the base (arrowheads). Native T1 map shows corresponding abnormality (arrowheads in (C)) ... |
PMC9416085_tomography-08-00164-f004_386589.jpg | What is the principal component of this image? | Magnetic Resonance Imaging of Case 2. Post-contrast magnitude inversion recovery (MAG-IR) (A) and phase-sensitive inversion recovery (PSIR) (B) images in short-axis views show subepicardial enhancement in the inferolateral wall at the base (arrowheads). Native T1 map shows corresponding abnormality (arrowheads in (C)) ... |
PMC9416097_viruses-14-01810-f003_386592.jpg | What's the most prominent thing you notice in this picture? | Observation of morphology under a transmission electron microscope (red arrow). (a) Recombinant proteins ADDomer; (b) recombinant proteins ADDomer-RBT. |
PMC9416097_viruses-14-01810-f003_386593.jpg | What is the dominant medical problem in this image? | Observation of morphology under a transmission electron microscope (red arrow). (a) Recombinant proteins ADDomer; (b) recombinant proteins ADDomer-RBT. |
PMC9416103_polymers-14-03340-f004_386594.jpg | What is the core subject represented in this visual? | HAp and EGF promoted the adhesion and proliferation of MDA-MB-231: (a) on the third day of culture, only a small number of cells were observed to adhere to the smooth surface (gelatin) without EGF; (b) cell proliferation for EGF immobilized on the smooth surface (gelatin); (c) adhesion of many cells was observed on the... |
PMC9416103_polymers-14-03340-f004_386595.jpg | What is the core subject represented in this visual? | HAp and EGF promoted the adhesion and proliferation of MDA-MB-231: (a) on the third day of culture, only a small number of cells were observed to adhere to the smooth surface (gelatin) without EGF; (b) cell proliferation for EGF immobilized on the smooth surface (gelatin); (c) adhesion of many cells was observed on the... |
PMC9416103_polymers-14-03340-f004_386597.jpg | What is the principal component of this image? | HAp and EGF promoted the adhesion and proliferation of MDA-MB-231: (a) on the third day of culture, only a small number of cells were observed to adhere to the smooth surface (gelatin) without EGF; (b) cell proliferation for EGF immobilized on the smooth surface (gelatin); (c) adhesion of many cells was observed on the... |
PMC9416103_polymers-14-03340-f007_386598.jpg | What is the principal component of this image? | MDA-MB-231 metastasis on GHG scaffold: (a) MDA-MB-231 was dynamically cultured in GHG scaffold until the seventh day, and it was observed that the cells proliferated/metastasized slowly toward two-dimensional planes on the scaffold; (b) the EGF was immobilized on the scaffold where cells proliferated/metastasized in th... |
PMC9416103_polymers-14-03340-f007_386599.jpg | Describe the main subject of this image. | MDA-MB-231 metastasis on GHG scaffold: (a) MDA-MB-231 was dynamically cultured in GHG scaffold until the seventh day, and it was observed that the cells proliferated/metastasized slowly toward two-dimensional planes on the scaffold; (b) the EGF was immobilized on the scaffold where cells proliferated/metastasized in th... |
PMC9416103_polymers-14-03340-f007_386600.jpg | What is the focal point of this photograph? | MDA-MB-231 metastasis on GHG scaffold: (a) MDA-MB-231 was dynamically cultured in GHG scaffold until the seventh day, and it was observed that the cells proliferated/metastasized slowly toward two-dimensional planes on the scaffold; (b) the EGF was immobilized on the scaffold where cells proliferated/metastasized in th... |
PMC9416119_medicina-58-01043-f002_386601.jpg | What is the main focus of this visual representation? | Initial orthopantomography. |
PMC9416120_nanomaterials-12-02826-f002_386605.jpg | What object or scene is depicted here? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386606.jpg | Describe the main subject of this image. | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386604.jpg | What is the central feature of this picture? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386603.jpg | What stands out most in this visual? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386607.jpg | What can you see in this picture? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386602.jpg | What is the focal point of this photograph? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416120_nanomaterials-12-02826-f002_386609.jpg | What is the principal component of this image? | Superparamagnetic iron oxide NPs being used in liver imaging and lymph node imaging. (A,B): T2-weighted MR image of a liver with a large hepatocellular carcinoma before (A) and after (B) the administration of SPION. The lesion is demarcated with arrows. (C,D): Standard (C) and SPION-based contrast-enhanced (D) MR imagi... |
PMC9416129_sensors-22-06122-f001_386610.jpg | What is shown in this image? | The robotic skin: the upper FSR sensors arranged in a rectangular pattern placed on a plastic foil, and the lower conductive layer of comb electrodes printed on plastic foil. |
PMC9416162_pharmaceutics-14-01716-f006_386617.jpg | Can you identify the primary element in this image? | Visualization of retinal cryosections via confocal microscopy. (A) Control samples: untreated and laser treated. (B) Treated samples: application of ICG liposomes on top of bovine retinal explants followed by laser treatment with 800 nm pulsed laser light. Blue: Hoechst staining to visualize nuclei. Red: immunostaining... |
PMC9416162_pharmaceutics-14-01716-f006_386611.jpg | What is the dominant medical problem in this image? | Visualization of retinal cryosections via confocal microscopy. (A) Control samples: untreated and laser treated. (B) Treated samples: application of ICG liposomes on top of bovine retinal explants followed by laser treatment with 800 nm pulsed laser light. Blue: Hoechst staining to visualize nuclei. Red: immunostaining... |
PMC9416162_pharmaceutics-14-01716-f006_386612.jpg | What is the main focus of this visual representation? | Visualization of retinal cryosections via confocal microscopy. (A) Control samples: untreated and laser treated. (B) Treated samples: application of ICG liposomes on top of bovine retinal explants followed by laser treatment with 800 nm pulsed laser light. Blue: Hoechst staining to visualize nuclei. Red: immunostaining... |
PMC9416162_pharmaceutics-14-01716-f006_386618.jpg | What object or scene is depicted here? | Visualization of retinal cryosections via confocal microscopy. (A) Control samples: untreated and laser treated. (B) Treated samples: application of ICG liposomes on top of bovine retinal explants followed by laser treatment with 800 nm pulsed laser light. Blue: Hoechst staining to visualize nuclei. Red: immunostaining... |
PMC9416162_pharmaceutics-14-01716-f006_386615.jpg | What is the dominant medical problem in this image? | Visualization of retinal cryosections via confocal microscopy. (A) Control samples: untreated and laser treated. (B) Treated samples: application of ICG liposomes on top of bovine retinal explants followed by laser treatment with 800 nm pulsed laser light. Blue: Hoechst staining to visualize nuclei. Red: immunostaining... |
PMC9416189_pharmaceutics-14-01645-f006_386619.jpg | What's the most prominent thing you notice in this picture? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386621.jpg | What is being portrayed in this visual content? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386626.jpg | What is the dominant medical problem in this image? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386632.jpg | What is being portrayed in this visual content? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386631.jpg | What is the central feature of this picture? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386630.jpg | What is the main focus of this visual representation? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386629.jpg | What is shown in this image? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.